Stockreport

Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy Co-Development and Manufacturing

Ocugen, Inc.  (OCGN) 
PDF Partnership to develop OCU400, Ocugen’s orphan drug designated gene therapy candidate in its modifier gene therapy platform MALVERN, Pa, & TIANJIN, China--(BUSINESS W [Read more]